You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Over a third of high-grade colposcopy referrals not seen within a month

By Dermot - 19th May 2020 | 6 views

Over a third of women (37 per cent) with high-grade referrals to colposcopy were not seen within the target of four weeks, according to data from January released by the HSE.

Furthermore, over half (56 per cent) of women with low-grade referrals were not seen within eight weeks.

“Owing to difficulties presented to the health service by Covid-19, we are not in a position to provide you with March or February data,” said a HSE spokesperson.

Data was not provided on urgent referrals, which have a two-week target. The Executive said it was unable to gather data on colposcopist vacancies owing to “difficulties posed by the impact of Covid-19 measures on staffing levels and redeployment”.

Meanwhile, the HSE confirmed that CervicalCheck made the technical transition to human papillomavirus (HPV) primary screening “as planned” on 30 March. Any test taken since this date will involve a HPV cervical screening test, with follow-up cytology if required.

“However, CervicalCheck has paused its cervical screening programme following the postponement of routine health appointments and procedures in order to redirect staff and resources to support the response to Covid-19. In making this decision, the health, wellbeing and safety of our service users continues to be our principal concern.

“Women who are currently being managed through the colposcopy clinics will continue to be treated, as hospital resources allow,” commented the HSE spokesperson on 24 April.

If a woman has had any symptoms, such as vaginal bleeding after sex, between periods or after the menopause; vaginal discharge that is not normal for her; persistent back or stomach pains; or pain during sex, she should contact her GP surgery, even if she has had a normal screening test recently.

The HSE said it will regularly review the decision to pause CervicalCheck “in line with the Government’s directive to stay at home to help slow the spread of Covid-19. Please see for more information.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]